Keyphrases
Kawasaki Disease
66%
Demyelinating Lesions
33%
Joint Infection
33%
Immunoprophylaxis
33%
Respiratory Syncytial Virus
33%
Respiratory Syncytial Virus Infection
33%
Soft Tissue Infection
33%
Upper Thoracic Spine
33%
Infections in children
33%
Bone Joint
33%
Recurrent Fever
33%
Bone Infection
33%
Skin Tissue
33%
Congenital Heart Disease
16%
Treatment Safety
16%
Infant Patients
16%
Future History
16%
Futures Past
16%
Respiratory Illness
16%
Airway Abnormalities
16%
Medical Providers
16%
Prolonged Fever
16%
Causes of Hospitalization
16%
Polyclonal Antibody
16%
Severe Disease
16%
Quality Improvement Project
16%
Pediatric Infectious Disease
16%
Immunodeficiency
16%
Fever of Unknown Origin
16%
Monoclonal Antibody
16%
Neuromuscular Disease
16%
Premature Infant
16%
Infectious Diseases
16%
Clinical Practice Guidelines
16%
Past-present
16%
Treatment Efficacy
16%
All Ages
16%
Antibiotic Stewardship
16%
Lymphadenitis
16%
Meningoencephalitis
11%
Neurologic Complications
11%
Neurological Outcome
11%
Neurologic Deficit
11%
Respiratory Agents
8%
RSV Disease
6%
Age at Vaccination
6%
Medicine and Dentistry
Kawasaki Disease
66%
Recurrent Fever
33%
Bone Infection
33%
Infectious Arthritis
33%
Soft Tissue Infection
33%
Social Distancing
33%
COVID-19
33%
Immunoprophylaxis
33%
Respiratory Syncytial Virus Infection
33%
Human Respiratory Syncytial Virus
33%
Infection
16%
Lymphadenitis
16%
Fever of Unknown Origin
16%
Clinical Guideline
16%
Pediatric Infection
16%
Quality Improvement
16%
Outpatient
16%
Antibiotics
16%
Respiratory Disease
16%
Persistent Truncus Arteriosus
16%
Immune Deficiency
16%
Prematurity
16%
Neuromuscular Disease
16%
Diseases
16%
Monoclonal Antibody
16%
Polyclonal Antibody
16%
Respiratory Agent
8%
Respiratory Tract Infection
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Pharmacology, Toxicology and Pharmaceutical Science
Mucocutaneous Lymph Node Syndrome
100%
Bone Infection
33%
Respiratory Syncytial Virus Infection
33%
Recurrent Fever
33%
Infection
33%
Soft Tissue Infection
33%
Infectious Arthritis
33%
Human Respiratory Syncytial Virus
33%
Neuromuscular Disease
16%
Immune Deficiency
16%
Lymphadenitis
16%
Pyrexia Idiopathica
16%
Polyclonal Antibody
16%
Prematurity
16%
Respiratory Tract Disease
16%
Congenital Heart Disease
16%
Antibiotics
16%
Disease
16%
Monoclonal Antibody
16%
Neurological Complication
11%
Meningoencephalitis
11%
SARS Coronavirus
8%
Respiratory Tract Infection
8%
